Mark D. Fielder

1.9k total citations
53 papers, 1.1k citations indexed

About

Mark D. Fielder is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Mark D. Fielder has authored 53 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 11 papers in Molecular Biology and 10 papers in Epidemiology. Recurrent topics in Mark D. Fielder's work include Antimicrobial Resistance in Staphylococcus (7 papers), Hepatitis C virus research (6 papers) and Spondyloarthritis Studies and Treatments (5 papers). Mark D. Fielder is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (7 papers), Hepatitis C virus research (6 papers) and Spondyloarthritis Studies and Treatments (5 papers). Mark D. Fielder collaborates with scholars based in United Kingdom, United States and Gambia. Mark D. Fielder's co-authors include Alison Kelly, Alan Ebringer, CR Wilson, Declan P. Naughton, Harmale Tiwana, Dorota Jamrozy, Allan Binder, Patrick Butaye, Camille Ettelaie and Sukhvinder S. Bansal and has published in prestigious journals such as PLoS ONE, Scientific Reports and Food Chemistry.

In The Last Decade

Mark D. Fielder

53 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark D. Fielder United Kingdom 20 306 233 228 165 162 53 1.1k
Claudio Foschi Italy 24 252 0.8× 609 2.6× 210 0.9× 156 0.9× 689 4.3× 95 1.8k
Chelsie E. Armbruster United States 22 224 0.7× 690 3.0× 77 0.3× 134 0.8× 786 4.9× 46 2.0k
Akbar Mirsalehian Iran 24 269 0.9× 390 1.7× 33 0.1× 110 0.7× 274 1.7× 60 1.4k
Sean Kennedy France 23 405 1.3× 1.0k 4.4× 51 0.2× 93 0.6× 264 1.6× 48 2.0k
Su‐Jin Park South Korea 27 1.1k 3.7× 376 1.6× 42 0.2× 188 1.1× 512 3.2× 80 1.9k
Reiko Kariyama Japan 23 578 1.9× 836 3.6× 42 0.2× 50 0.3× 296 1.8× 49 1.7k
Alice Friis‐Møller Denmark 22 212 0.7× 320 1.4× 29 0.1× 158 1.0× 226 1.4× 66 1.2k
M. Neal Guentzel United States 27 449 1.5× 577 2.5× 38 0.2× 682 4.1× 496 3.1× 77 2.1k
Catherine Dunyach‐Remy France 24 526 1.7× 667 2.9× 29 0.1× 133 0.8× 266 1.6× 89 2.0k
Andrea Petrucca Italy 22 183 0.6× 573 2.5× 18 0.1× 127 0.8× 275 1.7× 47 1.5k

Countries citing papers authored by Mark D. Fielder

Since Specialization
Citations

This map shows the geographic impact of Mark D. Fielder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Fielder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Fielder more than expected).

Fields of papers citing papers by Mark D. Fielder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark D. Fielder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Fielder. The network helps show where Mark D. Fielder may publish in the future.

Co-authorship network of co-authors of Mark D. Fielder

This figure shows the co-authorship network connecting the top 25 collaborators of Mark D. Fielder. A scholar is included among the top collaborators of Mark D. Fielder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark D. Fielder. Mark D. Fielder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vandrevala, Tushna, et al.. (2022). Willingness of the UK public to volunteer for testing in relation to the COVID-19 pandemic. BMC Public Health. 22(1). 565–565. 6 indexed citations
2.
3.
Li, Hongying, Yufei Chen, Catherine Machalaba, et al.. (2021). Wild animal and zoonotic disease risk management and regulation in China: Examining gaps and One Health opportunities in scope, mandates, and monitoring systems. One Health. 13. 100301–100301. 31 indexed citations
4.
Fielder, Mark D., et al.. (2017). Synthetic scale-up of a novel fluorescent probe and its biological evaluation for surface detection of Staphylococcus aureus. Molecular and Cellular Probes. 36. 1–9. 1 indexed citations
5.
Wedley, Amy, Susan Dawson, Thomas W. Maddox, et al.. (2014). Carriage of Staphylococcus species in the veterinary visiting dog population in mainland UK: Molecular characterisation of resistance and virulence. Veterinary Microbiology. 170(1-2). 81–88. 39 indexed citations
6.
Epstein, Jonathan H., Michelle L. Baker, Carlos Zambrana‐Torrelio, et al.. (2013). Duration of Maternal Antibodies against Canine Distemper Virus and Hendra Virus in Pteropid Bats. PLoS ONE. 8(6). e67584–e67584. 34 indexed citations
7.
Khatri, Bhagwati, Mark D. Fielder, Gareth J. Jones, et al.. (2013). High Throughput Phenotypic Analysis of Mycobacterium tuberculosis and Mycobacterium bovis Strains' Metabolism Using Biolog Phenotype Microarrays. PLoS ONE. 8(1). e52673–e52673. 38 indexed citations
8.
Sinclair, Alex, et al.. (2013). Development of an in situ culture-free screening test for the rapid detection of Staphylococcus aureus within healthcare environments. Organic & Biomolecular Chemistry. 11(20). 3307–3307. 3 indexed citations
9.
Gresley, Adam Le, et al.. (2012). The application of high resolution diffusion NMR to the analysis of manuka honey. Food Chemistry. 135(4). 2879–2886. 26 indexed citations
10.
Cottell, Jennifer L., Laura J. V. Piddock, Guanghui Wu, et al.. (2012). Detection and characterization of pCT-like plasmid vectors for blaCTX-M-14 in Escherichia coli isolates from humans, turkeys and cattle in England and Wales. Journal of Antimicrobial Chemotherapy. 67(7). 1639–1644. 33 indexed citations
11.
Rashid, Taha, Alan Ebringer, Harmale Tiwana, & Mark D. Fielder. (2009). Role of Klebsiella and collagens in Crohnʼs disease: a new prospect in the use of low-starch diet. European Journal of Gastroenterology & Hepatology. 21(8). 843–849. 15 indexed citations
12.
13.
Thompson, I. Richard, et al.. (2009). An alternative methodology for the prediction of adherence to anti HIV treatment. AIDS Research and Therapy. 6(1). 9–9. 6 indexed citations
14.
Fielder, Mark D., et al.. (2009). Anti-microbial activities of pomegranate rind extracts: enhancement by cupric sulphate against clinical isolates of S. aureus, MRSA and PVL positive CA-MSSA. BMC Complementary and Alternative Medicine. 9(1). 23–23. 33 indexed citations
15.
Afshar, Baharak, R. A. J. Nicholas, D.G. Pitcher, Mark D. Fielder, & R.J. Miles. (2009). Biochemical and genetic variation inMycoplasma fermentansstrains from cell line, human and animal sources. Journal of Applied Microbiology. 107(2). 498–505. 3 indexed citations
16.
Ayling, Roger D., et al.. (2007). A novel medium devoid of ruminant peptone for high yield growth of Mycoplasma ovipneumoniae. Veterinary Microbiology. 127(3-4). 309–314. 13 indexed citations
17.
Loria, Guido Ruggero, et al.. (2005). Biochemical characterisation of some non fermenting, non arginine hydrolysing mycoplasmas of ruminants. Veterinary Microbiology. 109(1-2). 129–134. 8 indexed citations
18.
Tiwana, Harmale, Mark D. Fielder, Allan Binder, et al.. (1995). Elevation in anti-Proteus antibodies in patients with rheumatoid arthritis from Bermuda and England.. PubMed. 22(10). 1825–8. 29 indexed citations
19.
Fielder, Mark D., Harmale Tiwana, Pierre Youinou, et al.. (1995). The specificity of the anti-Proteus antibody response in tissue-typed rheumatoid arthritis (RA) patients from Brest. Rheumatology International. 15(2). 79–82. 20 indexed citations
20.
Fielder, Mark D., S. J. Pirt, Ian Tarpey, et al.. (1995). Molecular mimicry and ankylosing spondylitis: possible role of a novel sequence in pullulanase of Klebsiella pneumoniae. FEBS Letters. 369(2-3). 243–248. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claudio Foschi Breakdown of academic impact, for papers by Chelsie E. Armbruster Breakdown of academic impact, for papers by Akbar Mirsalehian Breakdown of academic impact, for papers by Sean Kennedy Breakdown of academic impact, for papers by Su‐Jin Park Breakdown of academic impact, for papers by Reiko Kariyama Breakdown of academic impact, for papers by Alice Friis‐Møller Breakdown of academic impact, for papers by M. Neal Guentzel Breakdown of academic impact, for papers by Catherine Dunyach‐Remy Breakdown of academic impact, for papers by Andrea Petrucca
Rankless by CCL
2026